Tokyo Metropolitan Komagome Hospital

Bunkyō-Ku, Tokyo 113-8677

1 studies enrolling now · 1 studies all time

What they study most

Advanced Non-Small-Cell Lung Cancer, EGFR P-Loop and Alpha C-Helix Compressing, EGFR PACC, EGFR Uncommon Mutations, Metastatic Non-Small-Cell Lung Cancer, Non-Small-Cell Lung Cancer

Studies at this site

• Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations — Recruiting now